Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
From MaRDI portal
Publication:3317956
DOI10.2307/2530739zbMath0534.62074OpenAlexW2331522917WikidataQ71386294 ScholiaQ71386294MaRDI QIDQ3317956
Stephen D. Walter, Nicholas E. Day
Publication date: 1984
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2530739
sensitivitynegative exponential distributionchronic diseaseestimation proceduressojourn-time distributionHIP breast cancer screening projectsimplified models of screening
Related Items
A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detection, Scheduling optimal examination times in a simple illness-death model, Identifiability of the joint distribution of age and tumor size at detection in the presence of screening, Quantification of length‐bias in screening trials with covariate‐dependent test sensitivity, Treatment comparisons with screenable endpoints., A Conditional Approach to Measure Mortality Reductions Due to Cancer Screening, Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers, On the optimal policies of cancer screening, Computer simulation of randomized cancer screening trials to compare methods of estimating lead time and benefit time, A Stochastic Model for Calibrating the Survival Benefit of Screen-Detected Cancers, Early detection of disease and scheduling of screening examinations, Multivariate distributions of clinical covariates at the time of cancer detection, Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups, Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases, Generalized poisson regression model, An optimal design for simple illness-death model, Estimating distribution of the age of onset of detectable asymptomatic cancer, Dynamic Forecasting and Control Algorithms of Glaucoma Progression for Clinician Decision Support, Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends, Proportional Hazards Regression for Cancer Studies, Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing, Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial, MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening, On the application of mathematical models in maintenance, Screening for chronic diseases: optimizing lead time through balancing prescribed frequency and individual adherence, Modelling multi-stage processes through multivariate distributions, The genetics of breast and ovarian cancer IV: a model of breast cancer progression
